• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多叶准直器宽度对前列腺癌优势前列腺内病变前列腺内剂量分布计划的影响。

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer.

机构信息

Division of Radiation Oncology, Department of Molecular Genetics, Course for Molecular and Cellular Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.

出版信息

J Appl Clin Med Phys. 2010 Sep 7;11(4):3193. doi: 10.1120/jacmp.v11i4.3193.

DOI:10.1120/jacmp.v11i4.3193
PMID:21081876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5720410/
Abstract

The aim of this study was to investigate the impact of multileaf collimator width (MLC-W) on intraprostatic dose painting plans for prostate cancer.Prostate cancer maps based on the histopathological findings were superimposed onto simulation CT images. Clinical target volume (CTV) 1 was defined as the prostate and the base of the seminal vesicles, and CTV2 was defined as the dominant intraprostatic lesions. Planning target volume (PTV) 1 and PTV2 were delineated by adding 5 mm margins to CTV1 and CTV2, respectively. For each case, two dose painting plans were created to deliver 74 Gy to PTV1 and 84 Gy to PTV2 with dynamic multileaf collimator technique using two different MLCs: m3 (MLC-W: 3mm) and Millennium (5 mm). Plans were evaluated by comparing the conformation number (CN), a quantity that defines the degree of conformality.The CNs for plans using the m3 and Millennium were 0.68 and 0.67 for PTV1 and 0.59 and 0.58 for PTV2, respectively. The CNs tended to be higher for a thinner leaf width (p < 0.05).Dosimetric advantages associated with smaller leaves were observed. However, differences between 3 mm and 5 mm leaf width were relatively small, which suggested that 5 mm leaf width would be acceptable in dose painting plans for prostate cancer.

摘要

本研究旨在探讨多叶准直器宽度(MLC-W)对前列腺癌前列腺内剂量分布的影响。基于组织病理学发现的前列腺癌图谱被叠加到模拟 CT 图像上。临床靶区(CTV)1 定义为前列腺和精囊底,CTV2 定义为主要前列腺内病变。通过向 CTV1 和 CTV2 分别添加 5mm 边界,勾画计划靶区(PTV)1 和 PTV2。对于每个病例,使用两种不同的多叶准直器(m3,MLC-W:3mm 和 Millennium,5mm),采用动态多叶准直器技术创建两个剂量分布计划,将 74Gy 给到 PTV1,将 84Gy 给到 PTV2。通过比较适形度的定量指标——适形指数(CN)来评估计划。使用 m3 和 Millennium 的计划的 PTV1 的 CN 分别为 0.68 和 0.67,PTV2 的 CN 分别为 0.59 和 0.58。叶宽越窄,CN 值越高(p < 0.05)。较小叶片宽度存在剂量学优势。然而,3mm 和 5mm 叶宽之间的差异相对较小,这表明在前列腺癌的剂量分布计划中,5mm 叶宽是可以接受的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/8a5924f5087b/ACM2-11-144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/1cbadc236046/ACM2-11-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/df1ea6d1a35c/ACM2-11-144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/f3f2b39a09c0/ACM2-11-144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/8a5924f5087b/ACM2-11-144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/1cbadc236046/ACM2-11-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/df1ea6d1a35c/ACM2-11-144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/f3f2b39a09c0/ACM2-11-144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/5720410/8a5924f5087b/ACM2-11-144-g004.jpg

相似文献

1
Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer.多叶准直器宽度对前列腺癌优势前列腺内病变前列腺内剂量分布计划的影响。
J Appl Clin Med Phys. 2010 Sep 7;11(4):3193. doi: 10.1120/jacmp.v11i4.3193.
2
Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.前列腺癌的立体定向调强放射治疗:多叶准直器叶片宽度在调强放射治疗前列腺癌中的剂量学影响。
J Appl Clin Med Phys. 2004 Spring;5(2):29-41. doi: 10.1120/jacmp.v5i2.1989. Epub 2004 Apr 1.
3
Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.微型多叶准直器在前列腺癌调强放射治疗中的剂量学优势及临床意义
Med Dosim. 2005 Summer;30(2):97-103. doi: 10.1016/j.meddos.2005.03.002.
4
Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?前列腺癌靶区定义的差异会导致正常组织毒性出现临床相关差异吗?
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1076-81. doi: 10.1016/j.ijrobp.2004.05.005.
5
Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.根治性前列腺切除术后的解剖变异。对直肠和膀胱靶区体积定义及剂量体积参数的影响。
Strahlenther Onkol. 2004 Sep;180(9):563-72. doi: 10.1007/s00066-004-1245-y.
6
[Influence of high-definition multileaf collimator for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy of prostate cancer].[高清多叶准直器对前列腺癌三维适形放疗和调强放疗的影响]
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2012;68(7):825-34. doi: 10.6009/jjrt.2012_jsrt_68.7.825.
7
Effect of MLC leaf width on treatment adaptation and accuracy for concurrent irradiation of prostate and pelvic lymph nodes.多叶准直器叶片宽度对前列腺和盆腔淋巴结同期放疗的治疗适应和准确性的影响。
Med Phys. 2013 Jun;40(6):061701. doi: 10.1118/1.4803499.
8
Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.利用18F-胆碱PET/CT确定选择性前列腺内瘤床加量的原发性前列腺癌容积调强弧形放疗计划
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1017-25. doi: 10.1016/j.ijrobp.2014.12.052.
9
The impact of leaf width and plan complexity on DMLC tracking of prostate intensity modulated arc therapy.叶片宽度和计划复杂度对前列腺调强弧形治疗的 DMLC 跟踪的影响。
Med Phys. 2013 Nov;40(11):111717. doi: 10.1118/1.4824434.
10
Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.前列腺癌伴精囊和淋巴结的 RapidArc 放疗计划。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):935-42. doi: 10.1016/j.ijrobp.2009.07.1677. Epub 2010 Jan 8.

引用本文的文献

1
Two-fraction high-dose-rate brachytherapy within a single day combined with external beam radiotherapy for prostate cancer: single institution experience and outcomes.前列腺癌单日两次高剂量率近距离放疗联合外照射放疗:单机构经验与结果
J Radiat Res. 2016 Jun;57(3):280-7. doi: 10.1093/jrr/rrw003. Epub 2016 Mar 16.
2
Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.多叶准直器宽度对局限性前列腺癌大剂量调强放疗后晚期直肠出血发生率的临床影响
Int J Clin Oncol. 2016 Feb;21(1):156-61. doi: 10.1007/s10147-015-0873-9. Epub 2015 Jul 12.

本文引用的文献

1
Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions.准直器叶片宽度和治疗技术对颅内和颅外病变立体定向放射外科和放射治疗计划的影响。
Radiat Oncol. 2009 Jan 21;4:3. doi: 10.1186/1748-717X-4-3.
2
Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.在临床靶区体积和/或危及器官有显著差异的前列腺癌患者中,调强放疗(IMRT)的治疗计划结果始终优于适形放疗(3D-CRT)。
Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22.
3
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes.
局部前列腺癌的超高剂量(86.4 Gy)调强放射治疗:毒性反应及生化指标结果
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):330-7. doi: 10.1016/j.ijrobp.2007.10.004. Epub 2007 Dec 31.
4
Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study.调强放疗同步整合推量至95格雷治疗经活检证实、MRI界定的前列腺主要病灶:美国国立癌症研究所I期研究的早期结果
Radiat Oncol. 2007 Sep 18;2:36. doi: 10.1186/1748-717X-2-36.
5
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.前列腺癌中高剂量与标准剂量适形放疗的比较:MRC RT01随机对照试验的初步结果
Lancet Oncol. 2007 Jun;8(6):475-87. doi: 10.1016/S1470-2045(07)70143-2.
6
What dose of external-beam radiation is high enough for prostate cancer?多高剂量的外照射放疗对前列腺癌足够有效?
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):682-9. doi: 10.1016/j.ijrobp.2007.01.008. Epub 2007 Mar 29.
7
Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control.前列腺癌的调强放射治疗:晚期发病率及生化控制结果
Radiother Oncol. 2007 Feb;82(2):160-6. doi: 10.1016/j.radonc.2006.12.007. Epub 2007 Jan 12.
8
Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.高剂量调强放射治疗临床局限性前列腺癌患者的长期疗效
J Urol. 2006 Oct;176(4 Pt 1):1415-9. doi: 10.1016/j.juro.2006.06.002.
9
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.局限性前列腺癌放射治疗的剂量反应:荷兰多中心随机III期试验比较68 Gy与78 Gy放射治疗的结果
J Clin Oncol. 2006 May 1;24(13):1990-6. doi: 10.1200/JCO.2005.05.2530.
10
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.针对前列腺内主要病灶的调强放射治疗(IMRT)增敏剂量计划:基于金标记物的CT与动态对比增强及氢质子磁共振波谱成像(1H-spectroscopic MRI)的三维融合
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):291-303. doi: 10.1016/j.ijrobp.2005.12.046.